A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.

Several recent policy proposals are placing new pressures on the 340B drug pricing program, a decades-old federal initiative many hospitals and health systems depend on to offset the costs of care for ...

The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s estimates, and HRSA should delay the program’s ...

Stitt and other Republican governors argue that drug discounts can be used to support abortion services indirectly.

Hospitals and major drugmakers are battling over the financial impact of a government pilot program that could shake up how ...

The core problem in 340B runs deeper than poor oversight. The law requires steep discounts for purchased drugs but does not specify that the savings should be passed on to patients and insurance ...

A federal judge on Tuesday refused to block Maine from enforcing a new state law requiring drugmakers to offer discounts on ...

Americans assume hospitals are in the business of keeping us healthy, not of buying drugs inexpensively and then reselling ...

Republican governors, including Gov. Kevin Stitt, urge HRSA to revoke Planned Parenthood's eligibility for the 340B program.

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...